J 2025

Soft tissue reconstruction using Trevira tube following proximal femur resection and tumorous endoprosthetic replacement

APOSTOLOPOULOS, Vasileios; Michal MAHDAL; Lukáš PAZOUREK; Pavel BRANČÍK; Marian KUBÍČEK et al.

Základní údaje

Originální název

Soft tissue reconstruction using Trevira tube following proximal femur resection and tumorous endoprosthetic replacement

Autoři

APOSTOLOPOULOS, Vasileios; Michal MAHDAL; Lukáš PAZOUREK; Pavel BRANČÍK; Marian KUBÍČEK; Ioannis TRIKOUPIS; Panayiotis GAVRIIL; Petr BOHAC; Panayiotis J. PAPAGELOPOULOS a Tomáš TOMÁŠ

Vydání

BMC MUSCULOSKELETAL DISORDERS, LONDON, BMC, 2025, 1471-2474

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30211 Orthopaedics

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.400 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00142047

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

Trevira tube; Bone tumors; Proximal femur; Tumorous endoprosthesis megaendoprosthesis; Proximal femur replacement; Bipolar cup

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 27. 2. 2026 08:50, Mgr. Tereza Miškechová

Anotace

V originále

BackgroundThe use of Trevira tubes is beneficial for soft tissue reconstruction following proximal femur resection and endoprosthetic replacement, enhancing joint stability, mobility, and reducing abductor insufficiency. The purpose of the study is to describe the surgical technique and outcomes of soft tissue reconstruction using a Trevira tube following proximal femur resection for malignant bone tumors.MethodsThis study evaluates the outcomes of 80 patients who underwent proximal femur tumor replacement using dual-mobility hip systems with Trevira tubes in a sarcoma center. Reconstruction revision-free survival rate and failure modes were assessed using the Henderson classification, while functional outcomes were evaluated in 51 patients with a minimum six-month follow-up, assessed using the Harris Hip Score(HHS), Mayo Hip Score(MHS), Musculoskeletal Tumor Society Score(MSTS), Trendelenburg sign, and range of motion.ResultsThe five-year revision-free survival rate was 85.3%. The cumulative incidences at the five-year mark were 6.5% for dislocation and 8.1% for deep infection. Failures occurred predominantly in the early postoperative period (3 +/- 2.4 months). Functional outcomes (HHS: 78.71 +/- 12.55, MHS: 75.68 +/- 13.37 and MSTS: 24.11 +/- 3.22) were generally satisfactory, despite the frequent occurrence of abductor muscle insufficiency (37.3%). Statistically significant predictors of survival or functional outcomes were not identified. Nevertheless, trends indicate that patients with pathological fractures and metastases tend to have less favorable outcomes.ConclusionTrevira tube for soft tissue reconstruction following proximal femur resection and endoprosthetic replacement demonstrated promising results, with low failure rates and favorable functional outcomes. While no statistically significant predictors of survival or functional outcomes were identified, trends suggested poorer outcomes in patients with pathological fractures or metastatic bone disease.